The Neurontin legacy--marketing through misinformation and manipulation.
Landefeld
C Seth
CS
Division of Geriatrics, University of California, San Francisco, San Francisco, USA.
Steinman
Michael A
MA
D000588:Amines / Q000266:history*; D003509:Cyclohexanecarboxylic Acids / Q000266:history*; D004345:Drug Industry / Q000941:ethics / Q000266:history*; D004348:Drug Labeling / Q000266:history / Q000331:legislation & jurisprudence; D000077206:Gabapentin; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D040541:Marketing / Q000941:ethics / Q000266:history* / Q000331:legislation & jurisprudence; D014481:United States; D014486:United States Food and Drug Administration; D005680:gamma-Aminobutyric Acid / Q000266:history*
D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin